Pharmaceuticals
Israeli gas sensor spots ‘mirror’ molecules, opening path to breath-based diagnostics
By detecting subtle structural differences in volatile compounds, the sensors could power non-invasive breath tests for diseases such as lung cancer or diabetes.
Novo Nordisk advances amycretin to late-stage trial after positive diabetes weight-loss results
Teva seeks startups to help solve global pharmaceutical challenges
Trump warns pharmaceutical tariffs could reach 200%, gives 'a year to get their act together'
Israel’s healthcare workforce lags behind OECD averages despite growth in doctors and nurses
Despite an increase in medical professionals, Israel’s healthcare workforce remains below the OECD average, highlighting ongoing challenges.
Teva share price struggles to recover following $6 billion market loss
The financial results were actually positive, at the higher end of analysts' forecasts, but profit guidance for 2025 disappointed the market.
Israel on the pharma frontier: How AION Labs is incubating the next drug development breakthrough
The Inside Israeli Innovation Podcast: Season 2, Episode 43.
Immunai and Teva partner to innovate new cancer, immunology therapies
The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.
Israeli mapping company ImmunAI partners with AstraZeneca
The Israeli-American unicorn company ImmunAI has signed a multi-year cooperation agreement with the pharmaceutical giant AstraZeneca for the advanced optimization of clinical trials.
Immunai, AstraZeneca collaborate to optimize cancer clinical trials
Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.
Kahun’s pharma-focused AI agent: Bridging medical knowledge and patient care
Kahun’s new AI Agent is revolutionizing healthcare by providing real-time, patient-specific medical insights, helping doctors stay updated on pharmaceutical developments while improving patient care.
Mounjaro: the next big thing in weight loss, now heading to Israel
Mounjaro is a new-generation injection that mimics two hormones in the body: GLP-1 and GIP. These hormones influence several processes in the body, including blood sugar regulation and satiety.
Israel set to start selling pharmaceuticals outside of pharmacies
The Knesset Health Committee approved ordinances for the Pharmacists’ Regulations that would expand the list of active ingredients in drugs to be sold without a prescription and outside pharmacies
We must change the prejudices of mainstream medicine against lifestyle intervention - opinion
Lifestyle medicine prevents and reverses many chronic conditions and even auto-immune ones.
Pharma companies challenge lawsuit alleging terrorism funding activities in US Supreme Court
The companies have denied wrongdoing and said they "are not responsible in any way for the tragic events that were caused and carried out by Iraqi militia groups."
